This study reveals the critical epigenetic role of PUM1 in modulating DEPTOR‐dependent GC glycolytic metabolism, supporting further clinical investigation of PUM1 inhibitors as a metabolic‐targeting strategy for GC. This evidence concerns the gene PUM1 and gastric cancer.